Clarification request date:

02 November 2026 (Response date)

Clarification:

  • The company received communications from stock exchanges seeking clarification on a news report dated 30 October 2026 titled "India orders Sun Pharma to halt eye-care drug production at plant after quality lapses"
  • The clarification was also requested due to movement in the company's share price
  • The news report relates to developments that occurred in August 2026, not any new event on 30 October 2026
  • The matter was assessed at the relevant time (August 2026) and was not considered to warrant disclosure under Regulation 30 of SEBI Listing Regulations
  • The company announced its financial results for the quarter and half year ended 30 September 2026 on 30 October 2026 (same date as the news report)
  • The company is not in a position to attribute the share price movement to the news report or any particular factor
  • The company confirms it is not aware of any material event or information requiring disclosure under Regulation 30 that has not been disclosed